Hot Obesity Drug Market Will Keep Investors Gripped Next Year
(Bloomberg) -- Disappointing trial results for Novo Nordisk A/S’s experimental obesity shot capped a volatile year for investors in drug developers vying for a piece of pharma’s hottest market.Most Read from BloombergHo Chi Minh City Opens First Metro Line After Years of DelayReviving a Little-Known Modernist Landmark in BuffaloThe Architects Who Built MiamiNew York’s Congestion Pricing Plan Still Faces Legal HurdlesNew York City’s Historic Preservation Movement Is Having a Midlife CrisisNovo sh
Read More
Top analyst revisits Broadcom stock price target amid December surge
Broadcom shares have added around $250 billion in value this month.
Read More
Bitcoin price today: falls to $95k as Fed's hawkish tilt weighs
-- Bitcoin edged lower on Monday and traded in a narrow range after clocking steep losses last week, as traders remained cautious amid macroeconomic pressures induced...
Read More
Volkswagen shares fall as markets struggles to digest unions deal
Volkswagen shares were down 3% in early trade on Monday with analysts citing uncertainty about the automaker's cost-cutting deal with unions and likely headwinds in 2025. It fell short of management's initial ambitions and market expectations, and lacked a sense of urgency, according to Jefferies analyst Philippe Houchois. VW's earnings momentum is also unlikely to improve significantly next year given weak demand in China and potential tariffs after Donald Trump's election, they added.
Read More
Stock Market Today: Stocks mixed with Santa Claus boost in focus
Wall Street's 'Santa Claus Rally' has typically boosted stocks by around 1.3% over the final five trading days of the year, as well as the first two of the next.
Read More
Money market account rates today, December 23, 2024 (earn up to 5.00% APY)
Compare the best money market account rates available today and find out which banks have the best offers.
Read More
Wall Street Expected a Good Year for These 3 Stocks—What Happened?
These three stocks were expected to soar by double digits this year. Instead, they dropped by the same amount. What went wrong?
Read More
Bank of America customers seeing $0 balances amid nationwide outage
Tens of thousands of Bank of America customers have reported a network outage preventing them …
Read More
XRP Hits Strong Support Level, Is $93,000 Next for Bitcoin (BTC)? Dogecoin (DOGE) Dream of $1 Is Over?
U.Today - At this crucial point, XRP is testing the 26 EMA, a key support level that could dictate the asset's short-term course. After weeks of erratic price action, XRP is now at...
Read More
What's Next for Intel Stock After a Punishing Year? Some Say to 'Stay Far Away'
Investors in Intel's stock haven't had much to celebrate in 2024, with the shares losing more than half their value. Next year could be challenging too.
Read More
AI ignited a private market boom. Now wealthy investors want more
Wealthy investors are flocking to artificial intelligence startups — and fueling a private market renaissance.
Read More
Astros star posts cryptic 3-word comment after possible last game with Houston
Alex Bregman might see the writing on the wall. The Houston Astros were ousted from …
Read More
Wall Street’s ‘Santa Claus rally’ window is about to open with the Dow down in December
Stocks have struggled ahead of the holidays despite Friday’s rally.
Read More
Indian Banks Lobby RBI to Approve New Benchmark for Swaps Market
(Bloomberg) -- Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here.Most Read from BloombergHo Chi Minh City Opens First Metro Line After Years of DelayReviving a Little-Known Modernist Landmark in BuffaloThe Architects Who Built MiamiNew York’s Congestion Pricing Plan Still Faces Legal HurdlesNew York City’s Historic Preservation Movement Is Having a Midlife CrisisA group of Indian lenders has asked the centra
Read More